8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

Details for Australian Patent Application No. 2007224213 (hide)

Owner Theravance, Inc.

Inventors Jiang, Lan; Church, Timothy J.; Van Dyke, Priscilla; Long, Daniel; Dalziel, Sean; Stergiades, Ioanna; Preza, Leticia; Saito, Daisuke Roland; Jacobsen, John R.

Agent Davies Collison Cave

Pub. Number AU-B-2007224213

PCT Pub. Number WO2007/103187

Priority 60/841,028 30.08.06 US; 60/777,962 01.03.06 US

Filing date 28 February 2007

Wipo publication date 13 September 2007

Acceptance publication date 14 June 2012

International Classifications

C07D 451/02 (2006.01) Heterocyclic compounds containing condensed hetero ring systems

A61K 31/46 (2006.01) - 8-Azabicyclo [3.2.1] octane

A61P 1/10 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

Event Publications

18 September 2008 PCT application entered the National Phase

  PCT publication WO2007/103187 Priority application(s): WO2007/103187

14 June 2012 Application Accepted

  Published as AU-B-2007224213

11 October 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007224221-Processes for preparing morphinan6-one products with low levels of alpha, beta-unsaturated ketone compounds

2007224206-Assessing road traffic conditions using data from mobile data sources